Literature DB >> 33613516

Improved Functionality of Exhausted Intrahepatic CXCR5+ CD8+ T Cells Contributes to Chronic Antigen Clearance Upon Immunomodulation.

Kingsley Gideon Kumashie1, Marcin Cebula1, Claudia Hagedorn2, Florian Kreppel2, Marina C Pils3, Friedrich Koch-Nolte4, Björn Rissiek5, Dagmar Wirth1,6.   

Abstract

Chronic hepatotropic viral infections are characterized by exhausted CD8+ T cells in the presence of cognate antigen in the liver. The impairment of T cell response limits the control of chronic hepatotropic viruses. Immune-modulatory strategies are attractive options to re-invigorate exhausted T cells. However, in hepatotropic viral infections, the knowledge about immune-modulatory effects on the in-situ regulation of exhausted intrahepatic CD8+ T cells is limited. In this study, we elucidated the functional heterogeneity in the pool of exhausted CD8+ T cells in the liver of mice expressing the model antigen Ova in a fraction of hepatocytes. We found a subpopulation of intrahepatic CXCR5+ Ova-specific CD8+ T cells, which are profoundly cytotoxic, exhibiting efficient metabolic functions as well as improved memory recall and self-maintenance. The intrahepatic Ova-specific CXCR5+ CD8+ T cells are possibly tissue resident cells, which may rely largely on OXPHOS and glycolysis to fuel their cellular processes. Importantly, host conditioning with CpG oligonucleotide reinvigorates and promotes exhausted T cell expansion, facilitating complete antigen eradication. The CpG oligonucleotide-mediated reinvigoration may support resident memory T cell formation and the maintenance of CXCR5+ Ova-specific CD8+ T cells in the liver. These findings suggest that CpG oligodinucleotide may preferentially target CXCR5+ CD8+ T cells for expansion to facilitate the revival of exhausted T cells. Thus, therapeutic strategies aiming to expand CXCR5+ CD8+ T cells might provide a novel approach against chronic liver infection.
Copyright © 2021 Kumashie, Cebula, Hagedorn, Kreppel, Pils, Koch-Nolte, Rissiek and Wirth.

Entities:  

Keywords:  CXCR5+ T cells; CpG oligonucleotide; T cell exhaustion; T cell reinvigoration; exhausted stem-like T cells; follicular helper-like T cells; liver; liver resident T cells

Mesh:

Substances:

Year:  2021        PMID: 33613516      PMCID: PMC7886981          DOI: 10.3389/fimmu.2020.592328

Source DB:  PubMed          Journal:  Front Immunol        ISSN: 1664-3224            Impact factor:   7.561


  69 in total

1.  CXCR5+ CD8+ T Cells Indirectly Offer B Cell Help and Are Inversely Correlated with Viral Load in Chronic Hepatitis B Infection.

Authors:  Hang Jiang; Linhai Li; Jiang Han; Zhiwei Sun; Yihui Rong; Yun Jin
Journal:  DNA Cell Biol       Date:  2017-02-03       Impact factor: 3.311

Review 2.  ROS function in redox signaling and oxidative stress.

Authors:  Michael Schieber; Navdeep S Chandel
Journal:  Curr Biol       Date:  2014-05-19       Impact factor: 10.834

3.  Mitochondrial Priming by CD28.

Authors:  Ramon I Klein Geltink; David O'Sullivan; Mauro Corrado; Anna Bremser; Michael D Buck; Joerg M Buescher; Elke Firat; Xuekai Zhu; Gabriele Niedermann; George Caputa; Beth Kelly; Ursula Warthorst; Anne Rensing-Ehl; Ryan L Kyle; Lana Vandersarren; Jonathan D Curtis; Annette E Patterson; Simon Lawless; Katarzyna Grzes; Jing Qiu; David E Sanin; Oliver Kretz; Tobias B Huber; Sophie Janssens; Bart N Lambrecht; Angelika S Rambold; Edward J Pearce; Erika L Pearce
Journal:  Cell       Date:  2017-09-14       Impact factor: 41.582

4.  Epigenetic stability of exhausted T cells limits durability of reinvigoration by PD-1 blockade.

Authors:  Kristen E Pauken; Morgan A Sammons; Pamela M Odorizzi; Sasikanth Manne; Jernej Godec; Omar Khan; Adam M Drake; Zeyu Chen; Debattama R Sen; Makoto Kurachi; R Anthony Barnitz; Caroline Bartman; Bertram Bengsch; Alexander C Huang; Jason M Schenkel; Golnaz Vahedi; W Nicholas Haining; Shelley L Berger; E John Wherry
Journal:  Science       Date:  2016-10-27       Impact factor: 47.728

Review 5.  Tissue-Resident T Cells and Other Resident Leukocytes.

Authors:  David Masopust; Andrew G Soerens
Journal:  Annu Rev Immunol       Date:  2019-02-06       Impact factor: 28.527

Review 6.  CD28 Costimulation: From Mechanism to Therapy.

Authors:  Jonathan H Esensten; Ynes A Helou; Gaurav Chopra; Arthur Weiss; Jeffrey A Bluestone
Journal:  Immunity       Date:  2016-05-17       Impact factor: 31.745

Review 7.  CD8 T Cell Exhaustion in Chronic Infection and Cancer: Opportunities for Interventions.

Authors:  Masao Hashimoto; Alice O Kamphorst; Se Jin Im; Haydn T Kissick; Rathi N Pillai; Suresh S Ramalingam; Koichi Araki; Rafi Ahmed
Journal:  Annu Rev Med       Date:  2018-01-29       Impact factor: 13.739

8.  CXCR5+CD8+ T cells are a distinct functional subset with an antitumor activity.

Authors:  Fuliang Chu; Haiyan S Li; Xindong Liu; Jingjing Cao; Wencai Ma; Ying Ma; Jinsheng Weng; Zheng Zhu; Xiaoyun Cheng; Zhiqiang Wang; Jingwei Liu; Zi Yang Jiang; Amber U Luong; Weiyi Peng; Jing Wang; Kumudha Balakrishnan; Cassian Yee; Chen Dong; Richard Eric Davis; Stephanie S Watowich; Sattva S Neelapu
Journal:  Leukemia       Date:  2019-04-25       Impact factor: 11.528

Review 9.  T cell metabolism drives immunity.

Authors:  Michael D Buck; David O'Sullivan; Erika L Pearce
Journal:  J Exp Med       Date:  2015-08-10       Impact factor: 14.307

10.  Effective intrahepatic CD8+ T-cell immune responses are induced by low but not high numbers of antigen-expressing hepatocytes.

Authors:  Aaron Ochel; Marcin Cebula; Mathias Riehn; Upneet Hillebrand; Christoph Lipps; Reinhold Schirmbeck; Hansjörg Hauser; Dagmar Wirth
Journal:  Cell Mol Immunol       Date:  2015-10-12       Impact factor: 11.530

View more
  1 in total

Review 1.  Unraveling the Multifaceted Nature of CD8 T Cell Exhaustion Provides the Molecular Basis for Therapeutic T Cell Reconstitution in Chronic Hepatitis B and C.

Authors:  Valeria Barili; Andrea Vecchi; Marzia Rossi; Ilaria Montali; Camilla Tiezzi; Amalia Penna; Diletta Laccabue; Gabriele Missale; Paola Fisicaro; Carolina Boni
Journal:  Cells       Date:  2021-09-28       Impact factor: 6.600

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.